Please login to the form below

Not currently logged in
Email:
Password:

Vertex poaches new finance chief from Ironwood Pharmaceuticals

Boston-based biotech company appoints Tom Graney

Vertex Tom GraneyVertex lured Tom Graney away from Ironwood Pharmaceuticals, appointing him as its new senior vice president and chief financial officer.

He will join the Boston-based biotech firm next week, when he will be responsible for the development and execution of Vertex’s financial strategy and operations.

Graney will report to Vertex’s chief operating office Ian Smith, who said: “As Vertex continues its evolution to a leading global biotech, it is critical that we continue to build a strong and experienced leadership team.

“Tom has the ideal blend of financial acumen, leadership skills, and industry experience that will be important as Vertex grows and expands as a global company."

Graney most recently spent three years at Ironwood Pharmaceuticals, overseeing its Finance, Corporate Strategy, Corporate Development, Quality, Supply Chain, IT, Corporate Communications and Investor Relations functions.

Prior to that he served at Johnson & Johnson for 20 years in the US and abroad, rising to worldwide VP of finance and CFO for its Ethicon Surgical Care business.

At Ironwood Pharmaceuticals Graney’s replacement as interim chief financial officer will be Gina Consylman, who currently serves as the Cambridge, Massachusetts firm’s VP of finance and chief accounting officer.

8th September 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics